Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
-
-
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
-
US DFC announced $765 million loan to Eastman Kodak to support new expansion into pharmaceuticals
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
-
Todos Medical announced SARS-nCoV-19 testing kit contract with NJ-based best supply clinical laboratory
On Jul. 27, 2020, Todos Medical announced the Company has entered into a contract to supply NJ-based laboratory…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
-
A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
On Jul. 22, 2020, a study led by Albert Einstein College of Medicine and Montefiore Health System confirmed…
-
Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant
On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…
-
Pfizer pledged $100 million to new industry fund to help fight growing threat of antimicrobial resistance
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
-
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers formed collaboration to develop Emergent’s COVID-19 hyperimmune globulin product
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
-
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
OPKO Health’s BioReference Laboratories reports results of COVID-19 testing for almost one quarter of a million nursing home employees
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
-
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
-
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
-
SIGA Technologies announced deliveries of oral TPOXX to HHS valued at approximately $32 million
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
-
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
-
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
-
Pfizer announced start of four phase 3 clinical trials for investigational vaccines
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
-
Taconic Biosciences announced distribution of critical COVID-19 mouse model
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
-
COVID-19 pandemic dramatically increased out-of-hospital cardiac arrest cases and deaths in New York City
On Jun. 19, 2020, The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
-
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
-
Large Study at Mount Sinai Investigated the Effects of COVID-19 on Pregnancy Outcomes
On Jun. 18, 2020, a multidisciplinary team at Mount Sinai is conducting the first large-scale prospective study to…
-
The FDA revoked Emergency Use Authorization for Chembio antibody test
On Jun. 16, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) of…
-
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
-
SIGA Technologies announced Department of Defense increased funding to develop Post Exposure prophylactic indication for TPOXX
On Jun. 15, 2020, SIGA Technologies announced that it had been awarded a multi-year contract from the United…
-
Biotechnology | FDA | Medicine | Oncology | Pharmaceutical | Radiology | Therapeutics
FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo ® (nivolumab) was approved by the U.S. Food and…
-
Regeneron began first clinical trials of anti-viral antibody cocktail REGN-COV2 for treatment and prevention of COVID-19
On Jun. 11, 2020, Regeneron announced announced that Science has accepted for publication two papers describing the creation of…
-
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
-
Immunic announced FDA allowance of its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
-
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced initiation of preclinical immunization studies for its second COVID-19 vaccine platform. The…
